1027305-17-4Relevant academic research and scientific papers
Quinolones as HCV NS5B polymerase inhibitors
Kumar, Dange V.,Rai, Roopa,Brameld, Ken A.,Somoza, John R.,Rajagopalan, Ravi,Janc, James W.,Xia, Yu M.,Ton, Tony L.,Shaghafi, Michael B.,Hu, Huiyong,Lehoux, Isabelle,To, Nhat,Young, Wendy B.,Green, Michael J.
experimental part, p. 82 - 87 (2011/02/27)
Hepatitis C virus (HCV) infection is treated with a combination of peginterferon alfa-2a/b and ribavirin. To address the limitations of this therapy, numerous small molecule agents are in development, which act by directly affecting key steps in the viral
